Norway· NO-ID_4ED2FBBC-61D7-4AD9-9638-8DE22D2719E8

Lecigon

A levodopa, decarboxylasehemmer und comt-hemmer product containing entacapone + levodopa + carbidopa monohydrate, registered in Norway by Lobsor Pharmaceuticals AB. The same ATC class is registered in 12 of our 19 countries.

ATC N04BA03

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedLecigonATCN04BA03REGISTER NO.NO-ID_4ED2FBBC-61D7-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Levodopa, decarboxylasehemmer und comt-hemmer is registered in 12 of 19 countries.

Countries holding a registration under ATC N04BA03 (levodopa, decarboxylasehemmer und comt-hemmer), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Levodopa, decarboxylasehemmer und comt-hemmer · ATC N04BA03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levodopa, decarboxylasehemmer und comt-hemmer costs, country by country.

Normalised to the WHO defined daily dose (0.45 g), the median price runs from $1.36 in Italy to $5.49 in Switzerland — a ×4.0 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Levodopa, decarboxylasehemmer und comt-hemmer · price per daily dose (0.45 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.49
  • IT Italy$1.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Entacapone + Levodopa + Carbidopa Monohydrate
Manufacturer
Lobsor Pharmaceuticals AB
Country
Norway (NO)
ATC code
N04BA03
ATC class
Levodopa, Decarboxylasehemmer und COMT-Hemmer
Defined daily dose
0.45 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_4ED2FBBC-61D7-4AD9-9638-8DE22D2719E8
  • no_varenummer
    525575
    7 x 47
    NOK 7705
  • gtin
    7350116540017

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for levodopa, decarboxylasehemmer und comt-hemmer.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levodopa, decarboxylasehemmer und comt-hemmer · interactions on record

158 records

  • 4 severe
  • 122 moderate
  • 14 minor

Most severe, free to view

  • ProcarbazineL01XB01severe
  • OzanimodL04AA38severe
  • OzanimodL04AE02severe
  • Methylthioninium chlorideV03AB17severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levodopa, decarboxylasehemmer und comt-hemmer in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levodopa, decarboxylasehemmer und comt-hemmer products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Lecigimon, Trigelan
  • Belgium · Lecigen
  • Bulgaria · Лесигон
  • Czechia · Lecigimon, Trigelan
  • Germany · Lecigon, Levodopa/Carbidopa/Entacapon Abz
  • Denmark · Lecigon, Levodopa/Carbidopa/Entacapone G.L. Pharma
  • Estonia · Levodopa/Carbidopa/Entacapone Teva
  • Spain · Lecigon
  • Finland · Lecigon, Lecigon,
  • France · Lecigimon, Levodopa/Carbidopa/Entacapone Teva
  • United Kingdom (Northern Ireland) · Lecigon
  • Greece · Levodopa+carbidopa+entacapone Mylan
  • Croatia · Lecigon
  • Hungary · Lecigon, Levodopa/Carbidopa/Entacapone Teva
  • Ireland · Lecigon
  • Italy · Lecigimon, Levodopa/Carbidopa/Entacapone Mylan
  • Luxembourg · Lecigimon
  • Latvia · Levodopa/Carbidopa/Entacapone Teva
  • Netherlands · Lecigon, Levodopa/Carbidopa/Entacapon G.L. Pharma
  • Poland · Lecigon
  • Portugal · Lecigon
  • Romania · Lecigon, Levodopa/Carbidopa/Entacaponă Teva
  • Sweden · Lecigon, Levodopa/Carbidopa/Entacapone Pharmexon
  • Slovenia · Lecigon
  • Slovakia · Lecigon, Trigelan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e692ac94-5e6a-4d2c-b4d2-95618b2e7991
GET /v1/drugs/e692ac94-5e6a-4d2c-b4d2-95618b2e7991?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Intestinalgel",
  "source": "fest",
  "status": "A",
  "atc_name": "Levodopa, dekarboksylasehemmer og COMT-hemmer",
  "merkevare_id": "ID_4ED2FBBC-61D7-4AD9-9638-8DE22D2719E8",
  "name_form_strength": "Lecigon Intestinalgel 20 mg/ml/5 mg/ml/20 mg/ml",
  "prescription_group": "C"
}

See everything about levodopa, decarboxylasehemmer und comt-hemmer.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.